Genomic testing for targeted oncology drugs: hopes against hype
Ann Oncol
.
2021 Jul;32(7):837-838.
doi: 10.1016/j.annonc.2021.05.354.
Epub 2021 May 13.
Authors
R Dienstmann
1
,
D Tamborero
2
Affiliations
1
Oncoclínicas Precision Medicine, Oncoclínicas Group, Sao Paulo, Brazil; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Electronic address: rodrigo.dienstmann@oncoclinicas.com.
2
Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
PMID:
33992745
DOI:
10.1016/j.annonc.2021.05.354
No abstract available
Publication types
Editorial
Comment
MeSH terms
Genetic Testing
Hope
Humans
Neoplasms* / drug therapy
Neoplasms* / genetics
Pharmaceutical Preparations*
Substances
Pharmaceutical Preparations